UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

Journal of clinical oncology, 2018-05, Vol.36 (15), p.1486-1497

2018

Volltextzugriff (PDF)

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

The Journal of experimental medicine, 2016-07, Vol.213 (8), p.1513-1535

2016

Volltextzugriff (PDF)

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial

Haematologica (Roma), 2018-10, Vol.103 (10), p.1654

2018

Volltextzugriff (PDF)

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Blood, 2015-06, Vol.125 (25), p.3878-3885

2015

Volltextzugriff (PDF)

Massive cystic granulocytic sarcoma in a newly diagnosed patient with acute myeloid leukaemia

European journal of haematology, 2012-05, Vol.88 (5), p.462-462

2012

Volltextzugriff (PDF)

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial

Blood, 2023-11, Vol.142 (20), p.1697

2023

Volltextzugriff (PDF)

A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial

British journal of haematology, 2022-08, Vol.198 (3), p.528-534

2022

Volltextzugriff (PDF)

A Randomized Comparison of the Fractionated Versus Single Dose Schedule of Gemtuzumab Ozogamicin at Induction with Determinants of Benefit for Older AML Patients: UK NCRI AML18 Trial Results

Blood, 2022-11, Vol.140 (Supplement 1), p.532-533

2022

Volltextzugriff (PDF)

Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy

Blood, 2019-11, Vol.134 (Supplement_1), p.2935-2935

2019

Volltextzugriff (PDF)

The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

Leukemia, 2011-07, Vol.25 (7), p.1122-1127

2011

Volltextzugriff (PDF)

A tale of two tumours and a plea for progress

The lancet oncology, 2012-02, Vol.13 (2), p.124-125

2012

Volltextzugriff (PDF)

A Comparison of 1 or 2 Courses of High Dose Cytarabine As Consolidation in Younger Patients with AML: First Results of the UK NCRI AML17 Trial

Blood, 2015-12, Vol.126 (23), p.221-221

2015

Volltextzugriff (PDF)

A strange case of ingrowing toe nails

American journal of hematology, 2012-08, Vol.87 (8), p.819-819

2012

Volltextzugriff (PDF)

A Comparison of Daunorubicin/Ara-C (DA) Versus Daunorubicin/Clofarabine (DClo) and Two Versus Three Courses of Total Treatment for Older Patients with AML and High Risk MDS: Results of the UK NCRI AML16 Trial

Blood, 2012-11, Vol.120 (21), p.892-892

2012

Volltextzugriff (PDF)

Study on the Role of Recombinant Factor VIIa in the Management of Intractable Blood Loss in Patients without Inherited Bleeding Disorder in a UK District General Hospital

Blood, 2007-11, Vol.110 (11), p.3145-3145

2007

Volltextzugriff (PDF)

Echocardiography of Right Ventriculoarterial Coupling Combined With Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure

Chest, 2015-07, Vol.148 (1), p.226-234

2015

Volltextzugriff (PDF)

Impact of Cardiorespiratory Fitness on the Obesity Paradox in Patients With Heart Failure

Mayo Clinic proceedings, 2013-03, Vol.88 (3), p.251-258

2013

Volltextzugriff (PDF)

A neural network approach to predicting outcomes in heart failure using cardiopulmonary exercise testing

International journal of cardiology, 2014-02, Vol.171 (2), p.265-269

2014

Volltextzugriff (PDF)

A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure

Heart failure reviews, 2013, Vol.18 (1), p.79-94

2013

Volltextzugriff (PDF)

Validation of a cardiopulmonary exercise test score in heart failure

Circulation. Heart failure, 2013-03, Vol.6 (2), p.211-218

2013

Volltextzugriff (PDF)

Effects of Respiratory Exchange Ratio on the Prognostic Value of Peak Oxygen Consumption and Ventilatory Efficiency in Patients With Systolic Heart Failure

JACC. Heart failure, 2013-10, Vol.1 (5), p.427-432

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Life Sciences & Biomedicine
(26)
Science & Technology
(26)
Female
(20)
Male
(20)
Middle Aged
(19)
Aged
(17)
Adult
(16)
Prognosis
(12)
Cardiac & Cardiovascular Systems
(10)
Cardiovascular System & Cardiology
(10)
Biological And Medical Sciences
(8)
Exercise Test
(8)
Heart Failure
(8)
Heart Failure - Physiopathology
(8)
Hematology
(8)
Medical Sciences
(8)
Cardiovascular
(7)
Leukemia, Myeloid, Acute - Drug Therapy
(7)
Heart Failure - Diagnosis
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Massive cystic granulocytic sarcoma in a newly diagnosed patient with acute myeloid leukaemia

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

A randomised comparison of FLAG‐Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial

A Randomized Comparison of the Fractionated Versus Single Dose Schedule of Gemtuzumab Ozogamicin at Induction with Determinants of Benefit for Older AML Patients: UK NCRI AML18 Trial Results

High Molecular Response Rate and Overall Survival with FLT3 Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML

Interim Analysis of a Prospective Multicentre Study Using Next Generation Sequencing for Kinase Domain Mutational Analysis in CML Patients on First or Subsequent TKI Therapy

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

A tale of two tumours and a plea for progress

A Comparison of 1 or 2 Courses of High Dose Cytarabine As Consolidation in Younger Patients with AML: First Results of the UK NCRI AML17 Trial

A strange case of ingrowing toe nails

A Comparison of Daunorubicin/Ara-C (DA) Versus Daunorubicin/Clofarabine (DClo) and Two Versus Three Courses of Total Treatment for Older Patients with AML and High Risk MDS: Results of the UK NCRI AML16 Trial

Functional and Genetic Heterogeneity of Distinct Leukemic Stem Cell Populations in CD34- Human Acute Myeloid Leukemia

Study on the Role of Recombinant Factor VIIa in the Management of Intractable Blood Loss in Patients without Inherited Bleeding Disorder in a UK District General Hospital

Echocardiography of Right Ventriculoarterial Coupling Combined With Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure

Impact of Cardiorespiratory Fitness on the Obesity Paradox in Patients With Heart Failure

A neural network approach to predicting outcomes in heart failure using cardiopulmonary exercise testing

A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure

Validation of a cardiopulmonary exercise test score in heart failure

Effects of Respiratory Exchange Ratio on the Prognostic Value of Peak Oxygen Consumption and Ventilatory Efficiency in Patients With Systolic Heart Failure

Suchergebnisse filtern